Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSSFree Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

View Our Latest Report on Milestone Scientific

Milestone Scientific Price Performance

Shares of NYSE:MLSS opened at $1.27 on Tuesday. The business’s fifty day moving average price is $0.91 and its two-hundred day moving average price is $0.91. Milestone Scientific has a fifty-two week low of $0.54 and a fifty-two week high of $1.30. The stock has a market capitalization of $98.92 million, a price-to-earnings ratio of -18.14 and a beta of 1.10.

Hedge Funds Weigh In On Milestone Scientific

Hedge funds have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific during the 3rd quarter worth about $48,000. World Investment Advisors LLC bought a new position in Milestone Scientific during the 3rd quarter worth approximately $91,000. Carnegie Investment Counsel grew its holdings in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the period. Finally, Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Recommended Stories

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.